Melissa Tesher to Arthritis, Juvenile
This is a "connection" page, showing publications Melissa Tesher has written about Arthritis, Juvenile.
Connection Strength
3.705
-
Juvenile Fibromyalgia in Patients With Juvenile Idiopathic Arthritis: Utility of the Pain and Symptom Assessment Tool. Arthritis Care Res (Hoboken). 2022 12; 74(12):2085-2090.
Score: 0.860
-
The Role of Anti-IL-1 Medications in Autoinflammatory Disease. Pediatr Ann. 2022 Feb; 51(2):e72-e76.
Score: 0.828
-
The clinical spectrum of juvenile idiopathic arthritis in a large urban population. Curr Rheumatol Rep. 2012 Apr; 14(2):116-20.
Score: 0.419
-
2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Recommendations for Nonpharmacologic Therapies, Medication Monitoring, Immunizations, and Imaging. Arthritis Rheumatol. 2022 04; 74(4):570-585.
Score: 0.208
-
2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Oligoarthritis, Temporomandibular Joint Arthritis, and Systemic Juvenile Idiopathic Arthritis. Arthritis Care Res (Hoboken). 2022 04; 74(4):521-537.
Score: 0.208
-
2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Recommendations for Nonpharmacologic Therapies, Medication Monitoring, Immunizations, and Imaging. Arthritis Care Res (Hoboken). 2022 04; 74(4):505-520.
Score: 0.208
-
2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Oligoarthritis, Temporomandibular Joint Arthritis, and Systemic Juvenile Idiopathic Arthritis. Arthritis Rheumatol. 2022 04; 74(4):553-569.
Score: 0.208
-
Pilot Study of the Juvenile Dermatomyositis Consensus Treatment Plans: A CARRA Registry Study. J Rheumatol. 2021 01 01; 48(1):114-122.
Score: 0.182
-
Serum S100A8/A9 and S100A12 Levels in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis: Relationship to Maintenance of Clinically Inactive Disease During Anti-Tumor Necrosis Factor Therapy and Occurrence of Disease Flare After Discontinuation of Therapy. Arthritis Rheumatol. 2019 03; 71(3):451-459.
Score: 0.168
-
Risk, Timing, and Predictors of Disease Flare After Discontinuation of Anti-Tumor Necrosis Factor Therapy in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis With Clinically Inactive Disease. Arthritis Rheumatol. 2018 09; 70(9):1508-1518.
Score: 0.162
-
Pediatric Rheumatology. Pediatr Ann. 2015 Jun; 44(6):238-9.
Score: 0.130
-
A survey of steroid-related osteoporosis diagnosis, prevention and treatment practices of pediatric rheumatologists in North America. Pediatr Rheumatol Online J. 2014; 12:24.
Score: 0.123